학술논문
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor
Document Type
Article
Author
Fiskus, W.; Cuglievan, B.; Mill, C.P.; Birdwell, C.E.; Das, K.; Davis, J.A.; Hou, H.; Kadia, T.M.; Daver, N.; Sasaki, K.; Takahashi, K.; Hammond, D.; Reville, P.K.; Wang, J.; Loghavi, S.; Ruan, X.; Su, X.; Flores, L.B.; DiNardo, C.D.; Bhalla, K.N.; Piel, J.; Collins, M.; Hentemann, M.; Jain, A.; Malovannaya, A.; Sen, R.
Source
In: Blood . (Blood, 16 May 2024, 143(20):2059-2072)
Subject
Language
English
ISSN
15280020
00064971
00064971